DETECTRA at ACR Convergence 2024: Presenting Our Work on Digital Biomarkers for Rheumatoid Arthritis
At the ACR Convergence 2024 in Washington, D.C.—one of the most significant global gatherings in rheumatology—DETECTRA had the opportunity to present its ongoing research on remote patient monitoring.
Our abstract ‘Development of a Remote Patient Monitoring System Based on a Novel Digital Biomarker for Swelling in Rheumatoid Arthritis’ summarizes the research and technological developments that underpin DETECTRA’s solution:
This research focuses on the development of a digital biomarker capable of detecting and quantifying joint swelling in rheumatoid arthritis patients through self-imaging of the hands. Our solution leverages smartphone-based imaging to provide objective, visual data—an innovative complement to conventional clinical assessments, which often rely on subjective reporting.
The ACR Convergence provided a unique environment to share preliminary findings and gather feedback from the scientific community. This reinforces our commitment to developing evidence-based, digital tools that enhance remote monitoring and support more personalized treatment strategies in rheumatology.
We remain dedicated to advancing digital biomarkers and contributing to the future of patient-centered care.